The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer
- 11 April 2001
- Vol. 22 (4) , 689-699
- https://doi.org/10.1016/s0196-9781(01)00380-1
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Neuroendocrine cells in tumour growth of the prostate.Endocrine-Related Cancer, 1999
- Characterization of gastrin-releasing peptide receptors aberrantly expressed by non-antral gastric adenocarcinomasPeptides, 1999
- In situ hybridization for gastrin-releasing peptide receptor (GRP receptor) expression in prostatic carcinomaInternational Journal of Cancer, 1998
- A Human Gastric Cancer Cell Line Possesses a Functional Receptor for Gastrin-Releasing PeptideCancer Investigation, 1998
- Interaction of colocalized neuropeptides: functional significance in the circadian timing systemJournal of Neuroscience, 1991
- Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene ProductScience, 1991
- Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells.Proceedings of the National Academy of Sciences, 1991
- Bombesin stimulates growth of human prostatic cancer cellsin vitroCancer, 1990
- Bombesin: Central Nervous System Actions to Affect the Autonomic Nervous SystemaAnnals of the New York Academy of Sciences, 1988
- Bombesin Inhibits Growth of Human Pancreatic Adenocarcinoma in Nude MicePancreas, 1988